Dr. Reddy's Laboratories are an Indian multinational pharmaceutical company. The company is headquartered in Hyderabad, Telangana, India and Princeton, New Jersey, U.S. It was incorporated in
Dr Reddy's Laboratories Ltd
-(DRREDDY)
XNSE:DRREDDY, XBOM:DRREDDY
Dr. Reddy’s Laboratories (DRREDDY) Q3 FY22 Earnings Concall Transcript
Dr. Reddy's Laboratories (NSE:DRREDDY) Q3 FY22 Earnings Concall dated Jan. 28, 2022 Corporate Participants: Amit Agarwal -- Head of Investor Relations Parag
Infographic: All you need to know about Dr Reddy’s Labs Q2 performance
Dr. Reddy's Laboratories(NSE:DRREDDY) recently reported its second-quarter 2022 earnings results. The company had a consolidated revenue of ₹5,992 crores with a growth
Key highlights from Dr Reddy’s Q2 2022 earnings results
Dr Reddy’s Laboratories (NSE: DRREDDY) reported its second-quarter financial results for the period ended September 30, 2021. The company had total revenue
Dr.Reddy’s Laboratories Ltd (DRREDDY) Q3 FY21 Earnings Concall Transcript
Dr.Reddy's Laboratories Ltd (NSE: DRREDDY) Q3 FY21 earnings Concall dated Jan. 29, 2021. Corporate Participants: Amit Agarwal -- Head of Investor Relations